Antimicrobial resistant (AMR) Campylobacter is a global health threat; however, there is limited information on genomic determinants of resistance in low- and middle-income countries. We evaluated genomic determinants of AMR using a collection of whole genome sequenced Campylobacter jejuni and C. coli isolates from Iquitos, Peru. Campylobacter isolates from two paediatric cohort studies enriched with isolates that demonstrated resistance to ciprofloxacin and azithromycin were sequenced and mined for AMR determinants. The gyrA mutation leading to the Thr86Ile amino acid change was the only gyrA mutation associated with fluoroquinolone resistance identified. The A2075G mutation in 23S rRNA was present, but three other 23S rRNA mutations previously associated with macrolide resistance were not identified. A resistant-enhancing variant of the cmeABC efflux pump genotype (RE-cmeABC) was identified in 36.1% (35/97) of C. jejuni genomes and 17.9% (12/67) of C. coli genomes. Mutations identified in the CmeR-binding site, an inverted repeat sequence in the cmeABC promoter region that increases expression of the operon, were identified in 24/97 C. jejuni and 14/67 C. coli genomes. The presence of these variants, in addition to RE-cmeABC, was noted in 18 of the 24 C. jejuni and 9 of the 14 C. coli genomes. Both RE-cmeABC and mutations in the CmeR-binding site were strongly associated with the MDR phenotype in C. jejuni and C. coli. This is the first report of RE-cmeABC in Peru and suggests it is a major driver of resistance to the principal therapies used to treat human campylobacteriosis in this setting.
1 December 2020 in Environmental Science & Technology
The use of nontherapeutic broad-spectrum antimicrobial agents triclosan (TCS) and benzalkonium chloride (BC) can contribute to bacterial resistance to clinically relevant antibiotics. Antimicrobial-resistant bacteria within wastewater may reflect the resistance burden within the human microbiome, as antibiotics and pathogens in wastewater can track with clinically relevant parameters during perturbations to the community. In this study, we monitored culturable and resistant wastewater bacteria and cross-resistance to clinically relevant antibiotics to gauge the impact of each antimicrobial and identify factors influencing cross-resistance profiles. Bacteria resistant to TCS and BC were isolated from wastewater influent over 21 months, and cross-resistance, taxonomy, and monthly changes were characterized under both antimicrobial selection regimes. Cross-resistance profiles from each antimicrobial differed within and between taxa. BC-isolated bacteria had a significantly higher prevalence of resistance to “last-resort antibiotic” colistin, while isolates resistant to TCS exhibited higher rates of multidrug resistance. Prevalence of culturable TCS-resistant bacteria decreased over time following Food and Drug Administration (FDA) TCS bans. Cross-resistance patterns varied according to sampling date, including among the most clinically important antibiotics. Correlations between strain-specific resistance profiles were largely influenced by taxonomy, with some variations associated with sampling date. The results reveal that time, taxonomy, and selection by TCS and BC impact features of cross-resistance patterns among diverse wastewater microorganisms, which could reflect the variety of factors influencing resistance patterns relevant to a community microbiome.
6 June 2024 in The Journal of Molecular Diagnostics
Next-generation sequencing (NGS) has proven clinical utility on disease management and serves as an important tool for genomic surveillance. Currently, hurdles surrounding its implementation, namely the complex and demanding analytical workflows, have impeded its widespread use in many laboratories. To address this challenge, the UCLA Molecular Microbiology and Pathogen Genomics Laboratory evaluated the performance of the Tecan MagicPrep NGS system, a commercial automated solution for library preparation for clinical whole-genome sequencing assays, against the Illumina Nextera DNA Flex Library Prep. Using 35 unique organisms (28 bacteria and 7 fungi) for various clinical applications, including microbial identification and genomic characterization, we compared the quantity and quality of the prepared libraries and the resulting sequences, and concordance of the overall results. We also assessed the impact of its implementation on laboratory workflow. The MagicPrep NGS produced higher library concentrations with smaller sizes, and correspondingly, higher molarity. Quality metrics of the sequences, however, demonstrated no significant impact on the overall results, producing 100% concordance with the reference method. Importantly, workflow analysis showed 5 hours less hands-on time per run with more flexibility. This evaluation study indicates that performance of the MagicPrep NGS is comparable to the Nextera DNA Flex with the added benefit of improving workflow efficiency and reducing labor for performing routine clinical microbial whole-genome sequencing tests.
13 June 2025 in American Journal of Infection Control
Carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa (CP-CRPA) is a major public health threat due to limited treatment options and high transmissibility. Though widespread globally, few instances of locally transmitted New Delhi metallo-β-lactamase (NDM)-producing CP-CRPA have been documented in the United States. Here, a cluster of locally transmitted NDM-1 CP-CRPA infections in Southern California is reported. Epidemiologic investigations involving both patient screening and environmental surveillance by microbiological culture, carbapenemase testing, and bacterial whole-genome sequencing were conducted. Through extensive epidemiologic investigations, a sink environmental reservoir was identified. A genetically unique strain of NDM-CRPA was identified to be transmitted among seven patients in a single hospital over the course of 1.5 years. Changes in antimicrobial resistance genes harbored by a mobile genetic element were identified between the index and later cases, and the gene encoding NDM-1 resided within a mobile genetic element on the chromosome displaying evidence of widespread transmission between different species. Several interventions were implemented, including sink P-trap replacement and disinfectant against Pseudomonas biofilms. No additional cases were identified after the interventions. Implementation of real-time pathogen surveillance enabled effective response to an ongoing outbreak that involved environmental sampling, microbiological testing, whole-genome sequencing, facility management, and updated infection prevention policies.
Background: When people develop measles (cases), healthcare facility exposures are common and result in many potentially exposed people requiring resource-intensive control measures. We summarized exposures and transmission among people exposed to measles (contacts) in healthcare settings in New York City (NYC). Methods: NYC Health Department's surveillance data of NYC contacts exposed to measles cases in any NYC healthcare facility during December 2023–September 2025 were analyzed as a retrospective descriptive study. Characteristics summarized included measles transmission, immunity status, postexposure prophylaxis (PEP) administration, facility setting, and time of measles exposure. Results: Of 2122 healthcare contacts to 28 cases, no secondary cases occurred. 1285 (60.6%) were vaccinated or had other evidence of immunity, 618 (29.1%) were adults with unknown immunity, 124 (5.8%) were not immune and received PEP, and 95 (4.5%) were not immune and did not receive PEP. Most contacts were exposed in emergency departments and/or hospital inpatient settings (1406; 66.3%). Among 1028 contacts with known time of exposure (48.4% of all contacts), 785 (76.4%) overlapped with the case in the healthcare facility, 146 (14.2%) arrived within 1 hour, and 97 (9.4%) arrived 1–2 hours after the case left or were isolated. Conclusions: Most contacts exposed to measles in NYC healthcare facilities had presumptive immunity or were adults with unknown immunity. No transmission occurred among 2122 exposed contacts, including nonimmune contacts. Given no secondary transmission and resource-intensive control measures, relying solely on time-based measles exposure definitions may be overly broad. Incorporating strategies such as facility air exchange data might better assess transmission risk.
A 69-year-old female with type 2 diabetes (A1C 12.4%), hypertension, and hyperlipidemia presented to her dentist with a 2-day history of left-lower jaw pain (worse when chewing) and swelling. Her dentist identified pulpitis and periodontitis under the crown of her first molar (tooth number 19) and prescribed a 3-day course of methylprednisolone with clindamycin to reduce jaw swelling prior to an elective dental procedure. Three days later, she underwent an uneventful root canal treatment and crown replacement of tooth number 19. After the procedure, she noted worsening swelling and new development of facial numbness over the left masseter with resolution of the oral pain when chewing foods. By post-operative day 4, the swelling and pain progressed and radiated to the left temple and periauricular region, eventually culminating in left sided ptosis and trismus 7 days after her dental procedure. She presented to urgent care and was prescribed high-dose corticosteroids as her syndrome was suspected to be from giant cell arteritis and intraoral local anesthetics usage. A 2-day trial of steroids was ineffective—and she presented to the emergency department 10 days after her dental procedure with persistent left facial numbness, progressive left ptosis and visual loss, and hyperalgesia to her left maxilla and temple. There was no headache, nasal obstruction, purulent nasal discharge, or history of fever. On examination, she was afebrile with normal vital signs. Neurological examination was significant for left cranial nerve (CN) III, IV, and VI palsies. She had preserved visual acuity in her right eye and hand motion in the left eye. She was tender to palpation of the left jaw, temporal area, and sinuses. Oral examination revealed a painless and non-purulent hard palate ulcer ( Figure 1).